These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6362981)

  • 1. Determination of the hyperparameters of a prior probability model in survival analysis.
    Birch R; Bartolucci AA
    Comput Programs Biomed; 1983; 17(1-2):89-93. PubMed ID: 6362981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the duration of comparative clinical trials while allowing for cure.
    Sposto R; Sather HN
    J Chronic Dis; 1985; 38(8):683-90. PubMed ID: 4019705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A FORTRAN program for the design and analysis of sequential clinical trials.
    Whitehead J; Marek P
    Comput Biomed Res; 1985 Apr; 18(2):176-83. PubMed ID: 3838715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projection from previous studies: a Bayesian and frequentist compromise.
    Brown BW; Herson J; Atkinson EN; Rozell ME
    Control Clin Trials; 1987 Mar; 8(1):29-44. PubMed ID: 3568694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcomputer BASIC program to calculate the probability of graft and patient survival in renal transplantation.
    Offermann G
    Comput Methods Programs Biomed; 1988; 26(2):129-32. PubMed ID: 3282769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The principle of interval constraints: a generalization of the symmetric Dirichlet distribution.
    Neapolitan RE
    Math Biosci; 1991 Feb; 103(1):33-44. PubMed ID: 1804440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APL programs for outcome probabilities and confidence limits in sequential binomial trials.
    Larsen SO
    Control Clin Trials; 1984 Sep; 5(3):245-9. PubMed ID: 6548431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diagnostic method that uses causal knowledge and linear programming in the application of Bayes' formula.
    Cooper GF
    Comput Methods Programs Biomed; 1986 Apr; 22(2):223-37. PubMed ID: 3519071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination in clinical trials with an emphasis on exponentially distributed responses.
    Gross AJ; Hunt HH; Cantor AB; Clark BC
    Biometrics; 1987 Dec; 43(4):875-83. PubMed ID: 3427172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitation.
    Berchialla P; Zohar S; Baldi I
    Pharm Stat; 2019 Mar; 18(2):198-211. PubMed ID: 30440109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the number of exponential functions in pharmacokinetic models on the basis of concentration-time data by MUCOM1.
    Ulbrich M
    Methods Find Exp Clin Pharmacol; 1985 Dec; 7(12):653-9. PubMed ID: 3841683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On hierarchical Bayes procedures for predicting simple exponential survival.
    Geisser S
    Biometrics; 1990 Mar; 46(1):225-30. PubMed ID: 2350570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric estimation of a multivariate distribution in the presence of censoring.
    Hanley JA; Parnes MN
    Biometrics; 1983 Mar; 39(1):129-39. PubMed ID: 6871341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computers in paediatrics. 4. Computer program for evaluation of mortality rates.
    Tay JS; Yip WC
    J Singapore Paediatr Soc; 1982; 24(3-4):138-40. PubMed ID: 6897848
    [No Abstract]   [Full Text] [Related]  

  • 16. Using conditional maximization to determine hyperparameters in model-based fMRI.
    Rodriguez PF
    Neuroimage; 2010 Apr; 50(2):472-8. PubMed ID: 20026226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian inference of models and hyperparameters for robust optical-flow estimation.
    Héas P; Herzet C; Mémin E
    IEEE Trans Image Process; 2012 Apr; 21(4):1437-51. PubMed ID: 22167624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential allocation in clinical trials comparing two exponential survival curves.
    Louis TA
    Biometrics; 1977 Dec; 33(4):627-34. PubMed ID: 338043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning the size of survival time clinical trials with allowance for stratification.
    Moussa MA
    Stat Med; 1988 May; 7(5):559-69. PubMed ID: 3387715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.